Acurx Pharmaceuticals Statistics
Total Valuation
ACXP has a market cap or net worth of $8.62 million. The enterprise value is $5.30 million.
Important Dates
The last earnings date was Tuesday, March 18, 2025, before market open.
| Earnings Date | Mar 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ACXP has 22.04 million shares outstanding. The number of shares has increased by 27.56% in one year.
| Current Share Class | 22.04M |
| Shares Outstanding | 22.04M |
| Shares Change (YoY) | +27.56% |
| Shares Change (QoQ) | +3.46% |
| Owned by Insiders (%) | 11.67% |
| Owned by Institutions (%) | 11.21% |
| Float | 19.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 11.31 |
| P/TBV Ratio | 14.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.19
| Current Ratio | 1.19 |
| Quick Ratio | 1.16 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -534.03% and return on invested capital (ROIC) is -333.77%.
| Return on Equity (ROE) | -534.03% |
| Return on Assets (ROA) | -152.41% |
| Return on Invested Capital (ROIC) | -333.77% |
| Return on Capital Employed (ROCE) | -2,292.74% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.53M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.47% in the last 52 weeks. The beta is -1.71, so ACXP's price volatility has been lower than the market average.
| Beta (5Y) | -1.71 |
| 52-Week Price Change | -82.47% |
| 50-Day Moving Average | 0.65 |
| 200-Day Moving Average | 1.51 |
| Relative Strength Index (RSI) | 30.87 |
| Average Volume (20 Days) | 229,744 |
Short Selling Information
The latest short interest is 423,814, so 1.92% of the outstanding shares have been sold short.
| Short Interest | 423,814 |
| Short Previous Month | 452,814 |
| Short % of Shares Out | 1.92% |
| Short % of Float | 2.19% |
| Short Ratio (days to cover) | 0.86 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.10M |
| Pretax Income | -16.73M |
| Net Income | -14.10M |
| EBITDA | n/a |
| EBIT | -14.10M |
| Earnings Per Share (EPS) | -$0.87 |
Full Income StatementBalance Sheet
The company has $3.71 million in cash and n/a in debt, giving a net cash position of $3.71 million or $0.17 per share.
| Cash & Cash Equivalents | 3.71M |
| Total Debt | n/a |
| Net Cash | 3.71M |
| Net Cash Per Share | $0.17 |
| Equity (Book Value) | 615,121 |
| Book Value Per Share | 0.04 |
| Working Capital | 615,121 |
Full Balance SheetCash Flow
| Operating Cash Flow | -10.38M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |